The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumour-free ctDNA detection as a decision tool to support organ preservation in node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II NEO trial (CCTG CO.28).
 
Jonathan Loree
Consulting or Advisory Role - Advanced Accelerator Applications; AMGEN; Bayer; Guardant Health; Ipsen; Merck; Roche; Taiho Pharmaceutical
Research Funding - Ipsen (Inst); Personalis
 
Emma Titmuss
No Relationships to Disclose
 
Carl Brown
Honoraria - Ethicon/Johnson & Johnson
Other Relationship - Medtronic (Inst)
 
Thereasa Rich
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Dongsheng Tu
No Relationships to Disclose
 
Derek Jonker
Consulting or Advisory Role - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Ocellaris Pharma (Inst); Pfizer (Inst); SeaGen (Inst)
 
Christopher O'Callaghan
No Relationships to Disclose
 
Hagen Kennecke
Honoraria - Exelixis; Natera
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Natera
Research Funding - Exelixis (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)